Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 10, 2023 09:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
September 19, 2023 09:00 ET
|
Anika Therapeutics Inc.
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S. reverse...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
September 12, 2023 09:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
August 17, 2023 18:20 ET
|
Anika Therapeutics Inc.
Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure, resulting in higher strength and greater...
Anika Reports Second Quarter 2023 Financial Results
August 08, 2023 16:05 ET
|
Anika Therapeutics Inc.
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date Performance Hyalofast®, Single-Stage,...
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 20, 2023 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
July 12, 2023 09:00 ET
|
Anika Therapeutics Inc.
Anika’s new X-Twist™ Fixation System, combined with its ACE Award-Winning Tactoset® for hardware augmentation and autologous bone morrow aspirate, provide time-saving regenerative solutions for Sports...
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
May 30, 2023 16:05 ET
|
Anika Therapeutics Inc.
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S. where it has been clinically demonstrated to be...
Anika Reports First Quarter 2023 Financial Results
May 09, 2023 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for...